Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma

被引：6
作者：
Xu, Lin [1 ]
Wang, Boqing [1 ]
Ding, Wei [1 ]
机构：
[1] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Hepatopancreatobiliary Surg, Urumqi 830000, Peoples R China
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2017年 / 41卷 / 02期
关键词：
D O I：
10.1016/j.clinre.2016.12.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E24 / E25
页数：2
相关论文
共 5 条
  • [1] Aragon-Ching JB, ACTA ONCOL
  • [2] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
    Cervello, Melchiorre
    McCubrey, James A.
    Cusimano, Antonella
    Lampiasi, Nadia
    Azzolina, Antonina
    Montalto, Giuseppe
    [J]. ONCOTARGET, 2012, 3 (03) : 236 - 260
  • [3] Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
    Neptune, ER
    Frischmeyer, PA
    Arking, DE
    Myers, L
    Bunton, TE
    Gayraud, B
    Ramirez, F
    Sakai, LY
    Dietz, HC
    [J]. NATURE GENETICS, 2003, 33 (03) : 407 - 411
  • [4] Suarez C, 2010, ANN ONCOL, V21
  • [5] Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
    Wu, Shenhong
    Chen, John J.
    Kudelka, Andrzej
    Lu, Janice
    Zhu, Xiaolei
    [J]. LANCET ONCOLOGY, 2008, 9 (02) : 117 - 123
1